{
    "title": "Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.",
    "doc_id": "28434147",
    "writer": "Li H",
    "year": "2017",
    "summary": "Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or \"on-target/off-tumor\" toxicit â€¦",
    "abstract": "Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or \"on-target/off-tumor\" toxicity, adequate T cell infiltration and migration to solid tumors and T cell proliferation and persistence across the physical and biochemical barriers of solid tumors. In this review, we focus on the primary challenges and strategies to design safe and effective CAR T cells, including using novel cutting-edge technologies for CAR and vector designs to increase both the safety and efficacy, further T cell modification to overcome the tumor-associated immune suppression, and using gene editing technologies to generate universal CAR T cells. All these efforts promote the development and evolution of CAR T cell therapy and move toward our ultimate goal-curing cancer with high safety, high efficacy, and low cost.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/28434147/",
    "clean_text": "increasing the safety and efficacy of chimeric antigen receptor t cell therapy chimeric antigen receptor car t cell therapy is a promising cancer treatment that has recently been undergoing rapid development however there are still some major challenges including precise tumor targeting to avoid off target or on target off tumor toxicit chimeric antigen receptor car t cell therapy is a promising cancer treatment that has recently been undergoing rapid development however there are still some major challenges including precise tumor targeting to avoid off target or on target off tumor toxicity adequate t cell infiltration and migration to solid tumors and t cell proliferation and persistence across the physical and biochemical barriers of solid tumors in this review we focus on the primary challenges and strategies to design safe and effective car t cells including using novel cutting edge technologies for car and vector designs to increase both the safety and efficacy further t cell modification to overcome the tumor associated immune suppression and using gene editing technologies to generate universal car t cells all these efforts promote the development and evolution of car t cell therapy and move toward our ultimate goal curing cancer with high safety high efficacy and low cost"
}